Current Edition

Automated Identification of Cardiac Hypertrophy
Current Features

Automated Identification of Cardiac Hypertrophy Modulators Using a hipsc-derived Disease Model

Effective drug discovery and development rely heavily on the availability of predictive pre-clinical models. For decades, target-based drug discovery has focused on immortalised cells to …

Continue Reading →
Live Cell Imaging_Non-invasive Kinetic Data to Better
Current Features

Live Cell Imaging: Non-invasive Kinetic Data to Better Understand Cell Viability

The current assessment of cell viability depends on endpoint measurements. Unfortunately, this ignores the levels and rates of in-between measurements. However, advances in technology and …

Continue Reading →
Unlocking the Biomarker Revolution in Clinical Trials
Current Features

Unlocking the Biomarker Revolution in Clinical Trials

Completion of the first human genome sequence exactly 20 years ago opened up the tantalising prospect of a new era of precision treatments, with accurate …

Continue Reading →
Maximising mAbs Purification Efficiency_Focus Areas
Current Features

Maximising mAbs Purification Efficiency: Focus Areas for Reducing Bottlenecks in Downstream Processing

Finding ways to remove bottlenecks and improve yields in downstream processing for monoclonal antibodies (mAbs) continues to be a key focus area for biopharma manufacturers. …

Continue Reading →
High-throughput Sequencing Technologies are
Current Features

High-throughput Sequencing Technologies are Revolutionising Antibody Discovery

Therapeutics based on antibodies (Abs) are at the forefront of revolutionary treatments for cancer, autoimmunity and many other diseases. The application of high-throughput sequencing (HTS) …

Continue Reading →